Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryptogenic Organizing Pneumonia | 1 | 2014 | 5 | 0.510 |
Why?
|
| Sirolimus | 1 | 2014 | 169 | 0.450 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 426 | 0.370 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 977 | 0.340 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 621 | 0.330 |
Why?
|
| Laryngeal Neoplasms | 1 | 2023 | 89 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 763 | 0.170 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 10 | 0.160 |
Why?
|
| Retinoblastoma | 1 | 2018 | 28 | 0.160 |
Why?
|
| Optic Nerve | 1 | 2018 | 35 | 0.160 |
Why?
|
| Spinal Puncture | 1 | 2017 | 38 | 0.150 |
Why?
|
| Virtual Reality | 1 | 2017 | 21 | 0.150 |
Why?
|
| Fatal Outcome | 2 | 2015 | 293 | 0.150 |
Why?
|
| Radiology, Interventional | 1 | 2017 | 68 | 0.150 |
Why?
|
| Developing Countries | 1 | 2017 | 71 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3362 | 0.150 |
Why?
|
| Retina | 1 | 2018 | 213 | 0.140 |
Why?
|
| Simulation Training | 1 | 2017 | 88 | 0.140 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 173 | 0.140 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2015 | 18 | 0.130 |
Why?
|
| Medulloblastoma | 1 | 2015 | 36 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 100 | 0.130 |
Why?
|
| Everolimus | 1 | 2014 | 40 | 0.120 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 18 | 0.120 |
Why?
|
| Perforin | 1 | 2014 | 55 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 78 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2015 | 255 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2014 | 180 | 0.110 |
Why?
|
| Lymphoma | 1 | 2014 | 262 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 813 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 2 | 2023 | 552 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 938 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 878 | 0.080 |
Why?
|
| Jaundice, Obstructive | 1 | 2005 | 10 | 0.070 |
Why?
|
| Hepatic Duct, Common | 1 | 2005 | 9 | 0.070 |
Why?
|
| Common Bile Duct | 1 | 2005 | 19 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2005 | 63 | 0.060 |
Why?
|
| Embolism, Air | 1 | 2005 | 23 | 0.060 |
Why?
|
| Hamartoma | 1 | 2004 | 31 | 0.060 |
Why?
|
| Wounds, Gunshot | 1 | 2005 | 71 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 235 | 0.060 |
Why?
|
| Male | 7 | 2018 | 40965 | 0.060 |
Why?
|
| Humans | 11 | 2023 | 86643 | 0.060 |
Why?
|
| Laryngectomy | 1 | 2023 | 26 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2601 | 0.060 |
Why?
|
| Mutation | 1 | 2014 | 3968 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2360 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2018 | 3612 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 376 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8489 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 1686 | 0.050 |
Why?
|
| Middle Aged | 3 | 2014 | 25028 | 0.050 |
Why?
|
| Eye Enucleation | 1 | 2018 | 6 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 1939 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 736 | 0.040 |
Why?
|
| Proprioception | 1 | 2017 | 32 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2017 | 119 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2017 | 36 | 0.040 |
Why?
|
| Feedback | 1 | 2017 | 133 | 0.040 |
Why?
|
| Touch | 1 | 2017 | 89 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 108 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2017 | 185 | 0.040 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2015 | 33 | 0.030 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 2015 | 36 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 839 | 0.030 |
Why?
|
| Rituximab | 1 | 2014 | 116 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1673 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 579 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 381 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 329 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 294 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 3046 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3640 | 0.020 |
Why?
|
| Female | 4 | 2018 | 44532 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 25648 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2017 | 1004 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 8981 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5417 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3679 | 0.020 |
Why?
|
| Warfare | 1 | 2005 | 10 | 0.020 |
Why?
|
| Cholangiography | 1 | 2005 | 41 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 2438 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2005 | 150 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2005 | 177 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 826 | 0.010 |
Why?
|
| Pleural Neoplasms | 1 | 2005 | 188 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 18415 | 0.010 |
Why?
|